https://www.selleckchem.com/pr....oducts/SB-203580.htm
3%-66.7%) and increased on samples taken between 10 and 20days and20days since symptom onset (80%-96% and 92.9%-100%, respectively). From 20days after symptom onset, the Roche, Id-vet and Thermo Fisher assays all met the sensitivity (95%) and specificity (97%) targets determined by the WHO. Antibody signal response was significantly higher in the critically ill patient group. Antibody detection can complement rRT-PCR for the diagnosis of COVID-19, especially in the later stage, or in asymptomatic patients for epidemiologic
Like
Comment
Share
